Baxter's most recent trend suggests a bearish bias. One trading opportunity on Baxter is a Bear Call Spread using a strike $92.00 short call and a strike $97.00 long call offers a potential 34.77% return on risk over the next 14 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $92.00 by expiration. The full premium credit of $1.29 would be kept by the premium seller. The risk of $3.71 would be incurred if the stock rose above the $97.00 long call strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Baxter is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Baxter is bullish.
The RSI indicator is at 64.96 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Baxter
Medical Products Stock Earnings on Apr 30: BAX, IDXX & More
Wed, 29 Apr 2020 15:09:03 +0000
The medical product companies have partially mitigated the impact of the pandemic driven by the massive adoption of COVID-19 related healthcare-support products and services.
Baxter to Present at the UBS Virtual Global Healthcare Conference
Mon, 27 Apr 2020 20:15:00 +0000
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the UBS Virtual Global Healthcare Conference on Tuesday, May 19, 2020 via webcast. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 10:00 a.m. Eastern Time.
Baxter (BAX) to Report Q1 Earnings: What's in the Offing?
Mon, 27 Apr 2020 13:54:01 +0000
Baxter's (BAX) first-quarter performance is likely to reflect growth in its six global business units.
ABIOMED (ABMD) to Report Q4 Earnings: What's in the Cards?
Fri, 24 Apr 2020 13:59:01 +0000
ABIOMED's (ABMD) fiscal fourth-quarter performance is likely to reflect growth in Impella product line.
Baxter to Present at the Virtual BofA Securities 2020 Health Care Conference
Thu, 23 Apr 2020 20:15:00 +0000
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the virtual BofA Securities 2020 Health Care Conference via webcast on Tuesday, May 12, 2020. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 10:20 a.m. Eastern Time.
Related Posts
Also on Market Tamer…
Follow Us on Facebook